Selective Estrogen Receptor-β Agonists Repress Transcription of Proinflammatory Genes
Authors:
- 1 January 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 180 (1) , 630-636
Abstract
In addition to their role in the development and function of the reproductive system, estrogens have significant anti-inflammatory properties. Although both estrogen receptors (ERs) can mediate anti-inflammatory actions, ERβ is a more desirable therapeutic target because ERα mediates the proliferative effects of estrogens on the mammary gland and uterus. In fact, selective ERβ agonists have beneficial effects in preclinical models involving inflammation without causing growth-promoting effects on the uterus or mammary gland. However, their mechanism of action is unclear. The purpose of this study was to use microarray analysis to determine whether ERβ-selective compounds produce their anti-inflammatory effects by repressing transcription of proinflammatory genes. We identified 49 genes that were activated by TNF-α in human osteosarcoma U2OS cells expressing ERβ. Estradiol treatment significantly reduced the activation by TNF-α on 18 genes via ERβ or ERα. Most repressed genes were inflammatory genes, such as TNF-α, IL-6, and CSF2. Three ERβ-selective compounds, ERB-041, WAY-202196, and WAY-214156, repressed the expression of these and other inflammatory genes. ERB-041 was the most ERβ-selective compound, whereas WAY-202196 and WAY-214156 were the most potent. The ERβ-selective compounds repressed inflammatory genes by recruiting the coactivator, SRC-2. ERB-041 also repressed cytokine genes in PBMCs, demonstrating that ERβ-selective estrogens have anti-inflammatory properties in immune cells. Our study suggests that the anti-inflammatory effects of ERB-041 and other ERβ-selective estrogens in animal models are due to transcriptional repression of proinflammatory genes. These compounds might represent a new class of drugs to treat inflammatory disorders.Keywords
This publication has 62 references indexed in Scilit:
- Advances in Male ContraceptionEndocrine Reviews, 2008
- Estrogen deficiency and bone loss: an inflammatory taleJournal of Clinical Investigation, 2006
- Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytesClinical Endocrinology, 2005
- Estrogen, inflammation and cardiovascular risk in women: a critical appraisalTrends in Endocrinology & Metabolism, 2004
- Estradiol and Selective Estrogen Receptor Modulators Differentially Regulate Target Genes with Estrogen Receptors α and βMolecular Biology of the Cell, 2004
- Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47DProceedings of the National Academy of Sciences, 2004
- The Role of Cytokines in Endometriosis*American Journal of Reproductive Immunology, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Tissue Distribution and Quantitative Analysis of Estrogen Receptor- (ER ) and Estrogen Receptor- (ER ) Messenger Ribonucleic Acid in the Wild-Type and ER -Knockout MouseEndocrinology, 1997
- Cytokines in the pathogenesis of osteoporosisOsteoporosis International, 1997